Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Semma Therapeutics
Sort By
Newest First
1 / 1
1 / 1
M&A
Vertex to Acquire Semma Therapeutics With a Goal of Developing Curative Cell-Based Treatments for Type 1 Diabetes
Vertex
PR-M09-19-NI-008
Sep 04, 2019
Diabetes
Preclinical Studies Bode Well for Diabetes Drug from Semma Therapeutics
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-M07-19-NI-009
Jul 10, 2019
